Beranda › Kanker (semua jenis) › Michigan › Ann Arbor
Uji klinis Kanker (semua jenis) di Ann Arbor, MI
25 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Ann Arbor (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of ASP3082 in Adults With Advanced Solid Tumors
Menerima pesertaFase 1
- Trinity Health Ann Arbor Hospital, Ypsilanti · 7 mi jauhnya
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Menerima pesertaStudi observasional
- University of Michigan, Ann Arbor
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Menerima pesertaFase 1
- University of Michigan, Ann Arbor
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Menerima pesertaFase 3
- University of Michigan Health System, Ann Arbor
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Menerima pesertaFase 3
- Quetzal Site 22, Ann Arbor
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Menerima pesertaFase 2
- Trinity Health Ann Arbor Hospital, Ann Arbor
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Menerima pesertaFase 2/3
- University Of Michigan Comprehensive Cancer Center, Ann Arbor
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Menerima pesertaFase 2
- University of Michigan, Ann Arbor
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Menerima pesertaFase 1/2
- University of Michigan Health System - Ann Arbor /ID# 271536, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Menerima pesertaFase 1
- University of Michigan, Ann Arbor
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- University of Michigan, Ann Arbor
Lurbinectedin in FET-Fused Tumors
Menerima pesertaFase 1/2
- University of Michigan, Ann Arbor
Prostate Active Surveillance Study
Menerima pesertaStudi observasional
- University of Michigan, Ann Arbor
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- C S Mott Children's Hospital, Ann Arbor
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Menerima pesertaFase 3
- University of Michigan, Ann Arbor
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Menerima pesertaFase 2
- C.S. Mott Children's Hospital, Ann Arbor
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi jauhnya
- dan 6 lainnya
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Menerima pesertaFase 2
- University of Michigan Health System - Ann Arbor /ID# 273511, Ann Arbor
Childhood Cancer Survivor Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- University of Michigan/Mott Children's Hospital, Ann Arbor
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Menerima peserta
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Menerima pesertaFase 1
- University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Menerima pesertaFase 2
- Kellogg Eye Center, Ann Arbor
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Menerima peserta
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Ann Arbor
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Menerima peserta
- University of Michigan Medical Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi jauhnya
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Studi lain di Ann Arbor
- Kanker Prostat27 studi
- Kanker Payudara26 studi
- Kanker Paru Non-Sel Kecil26 studi
- Kanker Kolorektal23 studi
- Kanker Paru23 studi
- Gagal Jantung22 studi
- Leukemia Mieloid Akut17 studi
- Penyakit Kardiovaskular16 studi
- Kanker Pankreas14 studi
- Melanoma12 studi
- Kanker Ginjal (Karsinoma Sel Renal)12 studi
- Karsinoma Sel Skuamosa Kepala dan Leher12 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.